KERX Financial Facts

Interest and other income, net: 103K
Total research and development: 6.43M
See Full Income Statement

Accounts payable and accrued expenses: 8.45M
Total assets: 92.55M
See Full Balance Sheet

Earnings History for Keryx Biopharmaceuticals Inc. (KERX)

  |   Expand Research on KERX
Next EPS Date 8/6/13 *Est. EPS Growth Rate +76.9% *Last Qtr.
Average EPS % Beat Rate -37.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.4%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
11/2/11 Q311 -$0.15-$0.12 -$0.03N/AN/A N/A / N/A N/A +150.3% Details
3/8/11 Q410 -$0.09-$0.06 -$0.03N/A$2.82M N/A / N/A N/A +92.5% Details
8/8/11 Q211 -$0.05-$0.03 -$0.02$5M$5M N/A / N/A N/A +120.1% Details
5/7/13 Q113 -$0.03-$0.01 -$0.02$7M$5.83M N/A / N/A N/A -4.1% Details
3/11/13 Q412 -$0.09-$0.08 -$0.01N/AN/A N/A / N/A N/A +4.2% Details
11/8/12 Q312 -$0.08-$0.07 -$0.01N/AN/A N/A / N/A N/A +223.2% Details
5/8/12 Q112 -$0.13-$0.12 -$0.01N/AN/A N/A / N/A N/A +443.3% Details
2/29/12 Q411 -$0.12-$0.14 +$0.02N/AN/A N/A / N/A N/A +130.7% Details
Like KERX Earnings? Also take a look at BMY, MRK, PCRX, PFE

KERX Earnings News